VEGFA and macular retinal edema: It was recently reported that the intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents, such as bevacizumab9,10, ranibizumab11, or aflibercept12, were more effective in resolving the macular edema and improving the best-corrected visual acuity (BCVA) than the other treatments.